Pernix Therapeutics, Inc. Completes Divesture of Non-Core Assets to Breckenridge Pharmaceutical, Inc.
Published: Sep 12, 2013
HOUSTON--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NASDAQ MKT: PTX), a specialty pharmaceutical company, today announced that it had completed the previously disclosed sale of certain non-core assets to Breckenridge Pharmaceutical, Inc.
Help employers find you! Check out all the jobs and post your resume.